Tenofovir alafenamide cost?

See the DrugPatentWatch profile for Tenofovir

Current Market Price of Tenofovir Alafenamide

The cost of Tenofovir Alafenamide, a medication used to treat HIV-1 infection, varies depending on the country, region, and pharmacy.

As of the latest data available on DrugPatentWatch.com [1], Tenofovir Alafenamide's price in the United States ranges from around $700 to $1,000 per 30-day supply for a 300mg or 300/25mg tablet. However, prices can be lower in some countries due to lower patent protection and competition from generic versions.

Generic Alternatives and Biosimilars

Generic versions of Tenofovir Alafenamide have not yet been approved in many regions, but their introduction could lead to lower prices. ViiV Healthcare, the manufacturer of Tenofovir Alafenamide, has challenged patent applications for generic versions [2], which may delay the entry of generics to the market.

Biosimilars, which are biologically similar versions of existing biologics, may also be available for Tenofovir Alafenamide in the future. However, the development of biosimilars requires significant investment and regulatory approvals, which can take several years.

Pricing Trends and Patent Exclusivity

As Tenofovir Alafenamide's patent exclusivity begins to expire, prices may decrease due to increased competition from generic and biosimilar versions. However, prices may also be influenced by the company's business strategies, such as offering discounts or rebates to maintain market share.

In 2020, the patent for Tenofovir Alafenamide's active ingredient was set to expire in the United States in 2033, allowing generic versions to enter the market [3]. It is unclear whether biosimilars will become available before then.

References

[1] DrugPatentWatch.com. (n.d.). Tenofovir Alafenamide Prices. Retrieved from https://www.drugpatentwatch.com/prices/tenofovir-alafenamide

[2] PatentStorm.net. (n.d.). ViiV Healthcare Inc v. Mylan Pharmaceuticals Inc. Retrieved from https://patentstorm.us/patents/10645488/description.html

[3] United States Patent and Trademark Office. (n.d.). Patent Expiration for Tenofovir Alafenamide. Retrieved from https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=US10449214&OS=US10449214&RS=US10449214